The association of opioid use disorder and homelessness nationally in the veterans health administration
- PMID: 33865213
- DOI: 10.1016/j.drugalcdep.2021.108714
The association of opioid use disorder and homelessness nationally in the veterans health administration
Abstract
Background: Substance use disorder (SUD) is a major risk factor for homelessness, but the specific association of opioid use disorder (OUD) and homelessness in the context of their shared risk factors has not been the focus of prior studies. We used national data from the United States Veterans Health Administration (VHA) to examine the association of OUD and homelessness in the context of shared risk factors.
Methods: In this cross-sectional analysis of veterans who received VHA care during Fiscal Year 2012 (N = 5,450,078), we compared the prevalence of OUD and other sociodemographic, and clinical factors among homeless and non-homeless veterans. We estimated the odds ratio for homelessness associated with OUD alone, and after adjusting for other factors through multivariate logistic regression.
Results: Homeless veterans had substantially higher prevalence of OUD than other VHA patients (7.7 % Vs 0.6 %) and OUD was associated with 13 times higher unadjusted odds of homelessness (Odds Ratio [OR] 13.36, 95 % CI 13.09-13.62), which decreased with adjustment for sociodemographic factors (black race, mean income and age), other SUD, medical, and psychiatric diagnoses (final OR 1.57, 95 % CI 1.53-1.61). Other SUDs (alcohol, cannabis, cocaine, and hallucinogens) showed similar or slightly higher odds of homelessness as OUD in the final model.
Conclusions: OUD was strongly associated with homelessness among US veterans although this association was largely but not entirely attenuated by shared sociodemographic and co-morbid risk factors including several other SUDs. Treatment of homeless veterans with OUD should address socio-economic vulnerabilities and other co-morbidities in addition to treatments for OUD.
Keywords: Homelessness; Medical comorbidity; Opioid use disorder; Psychiatric comorbidity; Substance use disorders.
Published by Elsevier B.V.
Similar articles
-
Opioid use disorder and homelessness in the Veterans Health Administration: The challenge of multimorbidity.J Opioid Manag. 2018 May/Jun;14(3):171-182. doi: 10.5055/jom.2018.0447. J Opioid Manag. 2018. PMID: 30044482
-
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.Addiction. 2021 Jan;116(1):96-104. doi: 10.1111/add.15116. Epub 2020 Jul 7. Addiction. 2021. PMID: 32428386
-
Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration.Drug Alcohol Depend. 2018 Feb 1;183:111-117. doi: 10.1016/j.drugalcdep.2017.10.017. Epub 2017 Dec 2. Drug Alcohol Depend. 2018. PMID: 29245103
-
Review of Reported Adverse Events Occurring Among the Homeless Veteran Population in the Veterans Health Administration.J Patient Saf. 2021 Dec 1;17(8):e821-e828. doi: 10.1097/PTS.0000000000000884. J Patient Saf. 2021. PMID: 34406986 Review.
-
The Impact of Homelessness on Mortality of Individuals Living in the United States: A Systematic Review of the Literature.J Health Care Poor Underserved. 2022;33(1):457-477. doi: 10.1353/hpu.2022.0035. J Health Care Poor Underserved. 2022. PMID: 35153234
Cited by
-
Repetitive transcranial magnetic stimulation for the treatment of suicidality in opioid use disorder: a pilot feasibility randomized controlled trial.Eur Psychiatry. 2025 Mar 5;68(1):e63. doi: 10.1192/j.eurpsy.2025.28. Eur Psychiatry. 2025. PMID: 40040511 Free PMC article. Clinical Trial.
-
Opioid use disorder (OUD) and treatment for opioid problems among OUD symptom subtypes in individuals misusing opioids.Drug Alcohol Depend Rep. 2024 Feb 14;10:100220. doi: 10.1016/j.dadr.2024.100220. eCollection 2024 Mar. Drug Alcohol Depend Rep. 2024. PMID: 38414666 Free PMC article.
-
Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness.Community Ment Health J. 2023 Feb;59(2):345-356. doi: 10.1007/s10597-022-01012-x. Epub 2022 Jul 29. Community Ment Health J. 2023. PMID: 35906435 Free PMC article.
-
Examining the benefit of a higher maintenance dose of extended-release buprenorphine in opioid-injecting participants treated for opioid use disorder.Harm Reduct J. 2023 Dec 2;20(1):173. doi: 10.1186/s12954-023-00906-7. Harm Reduct J. 2023. PMID: 38042801 Free PMC article. Clinical Trial.
-
U.S. Military veterans and the opioid overdose crisis: a review of risk factors and prevention efforts.Ann Med. 2022 Dec;54(1):1826-1838. doi: 10.1080/07853890.2022.2092896. Ann Med. 2022. PMID: 35792749 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical